Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule
Clinical trial NCT01641991 · COMPLETED
Trial details
- NCT number
- NCT01641991
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2013-03-01
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.